APOE and Alzheimer disease: A study with CSF markers in AD patients showed that patients with cortical microbleeds had lower levels of CSF Aβ40 and Aβ42 than those without microbleeds after adjusting age, sex, APOE ε4 presence, and WMH burden (61).